Clinical Trials List
Protocol NumberARGX-113-2005
2021-07-01 - 2022-11-01
Phase III
ICD-10D47.3
Essential (hemorrhagic) thrombocythemia
ICD-10D69.3
Immune thrombocytopenic purpura
ICD-10D69.41
Evans syndrome
ICD-10D69.42
Congenital and hereditary thrombocytopenia purpura
ICD-10D69.49
Other primary thrombocytopenia
ICD-9287.3
Primary thrombocytopenia
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
156 participants
